Literature DB >> 4086137

Trends in total mortality and mortality from heart disease in 26 countries from 1950 to 1978.

T J Thom, F H Epstein, J J Feldman, P E Leaverton.   

Abstract

Death rates for total mortality and for non-rheumatic heart disease and hypertension ('heart disease') are described for men and women ages 45-64 in six time periods during 1950-78 for 26 countries. Rates for men in high-rate countries are three times those in low-rate countries. This variation is more striking for men than women. There were marked increases for heart disease in men in most countries, but in 13 countries there was a slowing or reversal of that trend in the 1960's or 1970's or acceleration of an already downward trend. In 22 countries long-term declines for heart disease occurred in women. There was a widening of the north/south gradient in Europe and of the male/female ratio of heart disease mortality. Countries with high heart disease death rates in men had high ratios of heart disease to total death. Other countries experienced a rise in proportionate mortality. In women, proportionate mortality for heart disease remained flat or declined in most countries. In spite of these changes in rates, each country seems to have a range for heart disease mortality that is characteristic of its population and environmental setting so that profound changes in rates do not substantially alter their relative ranking. Our intent is to stimulate the search for reasons why heart disease mortality recently declined in some countries but not in others (already begun in the WHO-sponsored MONICA programme). Our forthcoming monograph on international mortality trends for the major causes of death will be a next step in this process.

Entities:  

Mesh:

Year:  1985        PMID: 4086137     DOI: 10.1093/ije/14.4.510

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  15 in total

1.  Gains in life expectancy after elimination of major causes of death: revised estimates taking into account the effect of competing causes.

Authors:  J P Mackenbach; A E Kunst; H Lautenbach; Y B Oei; F Bijlsma
Journal:  J Epidemiol Community Health       Date:  1999-01       Impact factor: 3.710

Review 2.  Risks and diagnosis of coronary artery disease in Hodgkin lymphoma survivors.

Authors:  Serhan Kupeli
Journal:  World J Cardiol       Date:  2014-07-26

3.  Prevalence of ischaemic heart disease: the Caerphilly and Speedwell surveys.

Authors:  D Bainton; I A Baker; P M Sweetnam; J W Yarnell; P C Elwood
Journal:  Br Heart J       Date:  1988-02

4.  Distribution and prevalence of major risk factors of noncommunicable diseases in selected countries: the WHO Inter-Health Programme.

Authors:  X Berrios; T Koponen; T Huiguang; N Khaltaev; P Puska; A Nissinen
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

5.  Does cigarette smoking have an independent effect on coronary heart disease incidence in the elderly?

Authors:  R Benfante; D Reed; J Frank
Journal:  Am J Public Health       Date:  1991-07       Impact factor: 9.308

6.  [Strategies for the prevention of cardiovascular diseases in the German Federal Republic].

Authors:  U Laaser; G Murza; W Gerdel; D Borgers
Journal:  Soz Praventivmed       Date:  1988

7.  [Incidence of use of various myocardial infarct treatments in 2 Swiss regions].

Authors:  J M Gothuey; V Wietlisbach; M Rickenbach; F Barazzoni; C la Vecchia
Journal:  Soz Praventivmed       Date:  1991

8.  The epidemiologic transition theory.

Authors:  J P Mackenbach
Journal:  J Epidemiol Community Health       Date:  1994-08       Impact factor: 3.710

9.  Local increases in coronary heart disease mortality among blacks and whites in the United States, 1985-1995.

Authors:  E Barnett; J Halverson
Journal:  Am J Public Health       Date:  2001-09       Impact factor: 9.308

10.  [Total plasma cholesterol and HDL in a Swiss population: what attitude and norms should be adopted?].

Authors:  B Burnand; D Hausser; M Rickenbach; C Platsoukas; F Gutzwiller
Journal:  Soz Praventivmed       Date:  1988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.